| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
14,577 |
13,003 |
$209K |
| 36415 |
Collection of venous blood by venipuncture |
30,535 |
24,754 |
$169K |
| 80061 |
Lipid panel |
13,878 |
12,269 |
$156K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,245 |
3,757 |
$102K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,012 |
1,894 |
$100K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,469 |
2,127 |
$80K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,217 |
2,868 |
$77K |
| 80053 |
Comprehensive metabolic panel |
8,660 |
7,660 |
$77K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,685 |
1,570 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,715 |
7,654 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,046 |
6,293 |
$51K |
| 81000 |
|
16,493 |
14,501 |
$48K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,006 |
5,329 |
$44K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,147 |
1,002 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,082 |
943 |
$31K |
| 82274 |
|
2,002 |
1,799 |
$25K |
| 84153 |
|
1,623 |
1,410 |
$24K |
| 85027 |
|
4,319 |
3,949 |
$23K |
| 84439 |
|
2,949 |
2,601 |
$22K |
| 82043 |
|
4,682 |
4,120 |
$21K |
| 86701 |
|
2,648 |
2,279 |
$20K |
| 84436 |
|
2,724 |
2,483 |
$15K |
| 87088 |
|
2,167 |
1,946 |
$15K |
| 84460 |
|
2,939 |
2,592 |
$13K |
| 84450 |
|
2,938 |
2,590 |
$13K |
| 82607 |
|
993 |
874 |
$12K |
| 84479 |
|
1,846 |
1,675 |
$9K |
| 86803 |
|
730 |
560 |
$9K |
| 82947 |
|
2,099 |
1,960 |
$7K |
| 80074 |
|
162 |
155 |
$6K |
| 86592 |
|
1,733 |
1,551 |
$6K |
| 85651 |
|
1,751 |
1,535 |
$5K |
| 82570 |
|
1,370 |
1,167 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
740 |
686 |
$5K |
| 87276 |
|
313 |
246 |
$4K |
| 82565 |
|
937 |
902 |
$4K |
| 82270 |
|
1,233 |
1,057 |
$4K |
| 85730 |
|
715 |
619 |
$4K |
| 84550 |
|
1,010 |
856 |
$4K |
| 87275 |
|
313 |
246 |
$3K |
| 85610 |
|
895 |
730 |
$3K |
| 84520 |
|
840 |
805 |
$3K |
| 82378 |
|
127 |
92 |
$2K |
| 86038 |
|
163 |
142 |
$2K |
| 80069 |
|
196 |
169 |
$2K |
| 82746 |
|
119 |
109 |
$1K |
| 83655 |
|
122 |
122 |
$1K |
| 84478 |
|
237 |
215 |
$1K |
| 87186 |
|
147 |
141 |
$939.88 |
| 86304 |
|
51 |
51 |
$898.09 |
| 82728 |
|
63 |
47 |
$815.28 |
| 82465 |
|
176 |
160 |
$713.63 |
| 83550 |
|
77 |
68 |
$568.84 |
| 86140 |
|
114 |
98 |
$528.27 |
| 80076 |
|
54 |
54 |
$372.31 |
| 87340 |
|
32 |
32 |
$278.72 |
| 84703 |
|
35 |
28 |
$228.18 |
| 82950 |
|
59 |
57 |
$211.29 |
| 84156 |
|
59 |
58 |
$131.09 |
| 80050 |
General health panel |
14 |
13 |
$127.91 |
| 83540 |
|
20 |
12 |
$122.93 |
| 83721 |
|
122 |
121 |
$93.20 |
| 81050 |
|
33 |
16 |
$90.09 |
| 87899 |
|
23 |
23 |
$43.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
362 |
322 |
$23.38 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
85 |
79 |
$0.80 |
| 3046F |
|
41 |
37 |
$0.00 |
| 3051F |
|
70 |
53 |
$0.00 |
| 3044F |
|
2,681 |
2,387 |
$0.00 |
| 3061F |
|
28 |
28 |
$0.00 |